Literature DB >> 31400198

Inactivation of Wild-Type p53 by Asparagine Endopeptidase in Glioblastoma: An Opportunity to Target the "Undruggable".

James J Manfredi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31400198      PMCID： PMC7156925          DOI： 10.1093/jnci/djz156

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  19 in total

Review 1.  Emerging insights into the molecular and cellular basis of glioblastoma.

Authors:  Gavin P Dunn; Mikael L Rinne; Jill Wykosky; Giannicola Genovese; Steven N Quayle; Ian F Dunn; Pankaj K Agarwalla; Milan G Chheda; Benito Campos; Alan Wang; Cameron Brennan; Keith L Ligon; Frank Furnari; Webster K Cavenee; Ronald A Depinho; Lynda Chin; William C Hahn
Journal:  Genes Dev       Date:  2012-04-15       Impact factor: 11.361

2.  Role of Asparagine Endopeptidase in Mediating Wild-Type p53 Inactivation of Glioblastoma.

Authors:  Yingying Lin; Keman Liao; Yifeng Miao; Zhongrun Qian; Zhaoyuan Fang; Xi Yang; Quanmin Nie; Gan Jiang; Jianhua Liu; Yiyi Yu; Jieqing Wan; Xiaohua Zhang; Yaomin Hu; Jiyao Jiang; Yongming Qiu
Journal:  J Natl Cancer Inst       Date:  2020-04-01       Impact factor: 13.506

Review 3.  Glioblastoma multiforme: a perspective on recent findings in human cancer and mouse models.

Authors:  Sang Kyun Lim; Sheila R Alcantara Llaguno; Renée M McKay; Luis F Parada
Journal:  BMB Rep       Date:  2011-03       Impact factor: 4.778

Review 4.  Mouse models of glioblastoma: lessons learned and questions to be answered.

Authors:  Loury Janbazian; Jason Karamchandani; Sunit Das
Journal:  J Neurooncol       Date:  2014-02-13       Impact factor: 4.130

5.  Biosynthetic processing of cathepsins and lysosomal degradation are abolished in asparaginyl endopeptidase-deficient mice.

Authors:  Kanae Shirahama-Noda; Akitsugu Yamamoto; Kazushi Sugihara; Noriyoshi Hashimoto; Masahide Asano; Mikio Nishimura; Ikuko Hara-Nishimura
Journal:  J Biol Chem       Date:  2003-05-29       Impact factor: 5.157

Review 6.  The Roles of MDM2 and MDMX in Cancer.

Authors:  Orit Karni-Schmidt; Maria Lokshin; Carol Prives
Journal:  Annu Rev Pathol       Date:  2016-03-17       Impact factor: 23.472

7.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

8.  Transcriptional regulation of the legumain gene by p53 in HCT116 cells.

Authors:  Takuya Yamane; Sato Murao; Izumi Kato-Ose; Lisa Kashima; Motoki Yuguchi; Miyuki Kozuka; Keisuke Takeuchi; Hisakazu Ogita; Iwao Ohkubo; Hiroyoshi Ariga
Journal:  Biochem Biophys Res Commun       Date:  2013-08-11       Impact factor: 3.575

Review 9.  Putting p53 in Context.

Authors:  Edward R Kastenhuber; Scott W Lowe
Journal:  Cell       Date:  2017-09-07       Impact factor: 41.582

Review 10.  MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer.

Authors:  Veronica Tisato; Rebecca Voltan; Arianna Gonelli; Paola Secchiero; Giorgio Zauli
Journal:  J Hematol Oncol       Date:  2017-07-03       Impact factor: 17.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.